The Effect of Multiple Doses of Esomeprazole on the Pharmacokinetics of a Single Oral Dose BI 3000202 in Healthy Male Subjects (an Open-label, Randomized, Two-way Cross-over Study)
Latest Information Update: 22 Nov 2024
At a glance
- Drugs BI 3000202 (Primary) ; Esomeprazole
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
Most Recent Events
- 17 Jul 2024 Status changed from recruiting to completed.
- 28 May 2024 Status changed from not yet recruiting to recruiting.
- 22 May 2024 New trial record